Literature DB >> 25027177

Comparison of the change in the dimension of the pulmonary vein ostia immediately after pulmonary vein isolation for atrial fibrillation-open irrigated-tip catheters versus non-irrigated conventional 4 mm-tip catheters.

Takashi Yamamoto1, Takumi Yamada, Yukihiko Yoshida, Yasuya Inden, Naoya Tsuboi, Hirohiko Suzuki, Monami Ando, Masayuki Shimano, Rei Shibata, Haruo Hirayama, Toyoaki Murohara.   

Abstract

INTRODUCTION: A difference in the lesion formation between open irrigated-tip (OITC) and non-irrigated 4-mm-tip catheters (NITC) may result in a difference in the dimension of the pulmonary vein (PV) ostia after PV isolation of atrial fibrillation (AF). This study evaluated the difference using intracardiac echocardiography (ICE) before and immediately after an extensive encircling PV isolation (EPVI) with an OITC and with an NITC. METHODS AND
RESULTS: We studied 100 consecutive patients (OITC group, 54; NITC group, 46) who received EPVI. Changes in the vessel, lumen, and wall thickness areas of the PVs were evaluated at the PV ostia by ICE. There were no significant differences in the baseline characteristics and acute success rate of the EPVI between the OITC and NITC groups. The energy delivered to achieve EPVI was higher in the OITC group than that in the NITC group (34,967 ± 13,222 J vs. 28,300 ± 10,614 J; p=0.01). After the ablation, the reduction in the vessel and lumen cross-sectional areas was significantly smaller in the OITC group than that in the NITC group (-9.05 ± 28.4 % vs. -21.2 ± 28.8 %, p<0.001; -8.76 % vs. -17.7 ± 26.9 %, p=0.003). The wall thickness area slightly decreased in the OITC group, but increased in the NITC group (-2.96 ± 38.4 % vs. 10.5 ± 76.6 %, p=0.591). During a median follow-up of 234 days, there was no significant difference in the AF recurrence after the initial ablation procedure between the two groups.
CONCLUSION: Greater PV ostial narrowing occurred with the NITC than OITC immediately after the EPVI. PV ostial wall edema was noted with only the NITC. These findings suggested that an OITC might reduce any acute PV narrowing and wall edema as compared with an NITC.

Entities:  

Mesh:

Year:  2014        PMID: 25027177     DOI: 10.1007/s10840-014-9919-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  23 in total

Review 1.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

2.  Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study.

Authors:  Sanjay Dixit; Edward P Gerstenfeld; David J Callans; Joshua M Cooper; David Lin; Andrea M Russo; Ralph J Verdino; Vickas V Patel; Stephen E Kimmel; Sarah J Ratcliffe; Henry H Hsia; Hemal M Nayak; Erica Zado; Jian-Fang Ren; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2006-07-18

3.  A decrease in pulmonary vein diameter after radiofrequency ablation predicts the development of severe stenosis.

Authors:  Alexander Berkowitsch; Thomas Neumann; Okan Ekinci; Harald Greiss; Thorsten Dill; Klaus Kurzidim; Malte Kuniss; Hans J Schneider; Heinz F Pitschner
Journal:  Pacing Clin Electrophysiol       Date:  2005-01       Impact factor: 1.976

4.  Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs.

Authors:  G W Taylor; G N Kay; X Zheng; S Bishop; R E Ideker
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

5.  Pulmonary vein stenosis and remodeling after electrical isolation for treatment of atrial fibrillation: short- and medium-term follow-up.

Authors:  Yuanzhe Jin; David L Ross; Stuart P Thomas
Journal:  Pacing Clin Electrophysiol       Date:  2004-10       Impact factor: 1.976

6.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

7.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Pulmonary vein stenosis by ostial irrigated-tip ablation: incidence, time course, and prediction.

Authors:  Helmut Pürerfellner; Rudolf Cihal; Josef Aichinger; Martin Martinek; Hans Joachim Nesser
Journal:  J Cardiovasc Electrophysiol       Date:  2003-02

9.  Impact of catheter ablation on pulmonary vein morphology and mechanical function.

Authors:  David Schwartzman; Hideaki Kanzaki; Raveen Bazaz; John Gorcsan
Journal:  J Cardiovasc Electrophysiol       Date:  2004-02

10.  Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: an electroanatomic study.

Authors:  Sabine Ernst; Feifan Ouyang; Felix Löber; Matthias Antz; Karl-Heinz Kuck
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

View more
  5 in total

1.  Medical treatment of a symptomatic acute pulmonary vein stenosis following antral pulmonary vein isolation.

Authors:  Taner Ulus; Muhammet Dural; Emre Şener; Pelin Meşe; Emel Kurt; Nevin Aydın
Journal:  J Atr Fibrillation       Date:  2020-02-28

2.  Impact of the pulmonary vein orifice area assessed using intracardiac echocardiography on the outcome of radiofrequency catheter ablation for atrial fibrillation.

Authors:  Takashi Nakashima; Masanori Kawasaki; Hiroyuki Toyoshi; Nobuhiro Takasugi; Tomoki Kubota; Hiromitsu Kanamori; Hiroaki Ushikoshi; Takuma Aoyama; Kazuhiko Nishigaki; Shinya Minatoguchi
Journal:  J Interv Card Electrophysiol       Date:  2018-02-14       Impact factor: 1.900

3.  Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.

Authors:  Luiz Pereira de Magalhães; Marcio Jansen de Oliveira Figueiredo; Fatima Dumas Cintra; Eduardo Benchimol Saad; Ricardo Ryoshim Kuniyoshi; Adalberto Menezes Lorga Filho; Andre Luiz Buchele D'Avila; Angelo Amato Vincenzo de Paola; Carlos Antonio Abunader Kalil; Dalmo Antonio Ribeiro Moreira; Dario Celestino Sobral Filho; Eduardo Back Sternick; Francisco Carlos da Costa Darrieux; Guilherme Fenelon; Gustavo Glotz de Lima; Jacob Atié; José Carlos Pachón Mateos; José Marcos Moreira; José Tarcísio Medeiros de Vasconcelos
Journal:  Arq Bras Cardiol       Date:  2016-12       Impact factor: 2.000

4.  Early and Delayed Alteration of Atrial Electrograms Around Single Radiofrequency Ablation Lesion.

Authors:  Stepan Havranek; Hana Alfredova; Zdenka Fingrova; Lucie Souckova; Dan Wichterle
Journal:  Front Cardiovasc Med       Date:  2019-01-08

5.  Safety and efficacy of the ThermoCool SmartTouch SurroundFlow catheter for atrial fibrillation ablation: A meta-analysis.

Authors:  Chao-Feng Chen; Xiao-Fei Gao; Mei-Jun Liu; Chao-Lun Jin; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2019-11-19       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.